Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Personalized Medicine
|
March 29, 2023
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
Biagio Barone, Marco Finati, Francesco Cinelli, et al.
Urologic Oncology
|
August 7, 2024
The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry
Courtney Yong, James E Slaven, Zhenjie Wu, et al.
BJU International
|
December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes
Dhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
World Journal of Urology
|
October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
Ugo G Falagario, Anna Lantz, Ivan Jambor, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Personalized Medicine
|
March 29, 2023
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
Biagio Barone, Marco Finati, Francesco Cinelli, et al.
Urologic Oncology
|
August 7, 2024
The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry
Courtney Yong, James E Slaven, Zhenjie Wu, et al.
BJU International
|
December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes
Dhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
World Journal of Urology
|
October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
Ugo G Falagario, Anna Lantz, Ivan Jambor, et al.
Page
of 5